CONGRESS 2009

Program & Downloads

Click here to download the entire book (139KB) – To navigate in the pages, please use the search tool or the bookmarks.

 

Click here to view the speakers list

Hepatitis C - Monday, January 19th 2009

  • 9:00 How to use the virological tools for the optimal follow up of chronic hepatitis C - Jean-Michel PAWLOTSKY (France)
  • 9:20 What are the co-morbidities influencing the management of patients and the response to therapy ? - Alfredo ALBERTI (Italy)
  • 9:40 Non invasive fibrosis markers and/or liver biopsy ? - Pierre BEDOSSA (France)
  • 10:00 Round table - All speakers
  • 10:30 - 11:00 Coffee break
  • 11:00 – 12:30 Optimizing therapy in real life illustrated with clinical cases - Chairpersons: Peter FERENCI (Austria) Graham FOSTER (UK)
  • 11:00 Optimizing therapy in real life illustrated with clinical cases Optimal therapy in genotype 1 patients - Stefan ZEUZEM (Germany)
  • 11:20 Optimal therapy in genotype 2 and 3 patients - Antonio CRAXI (Italy)
  • 11:40 Optimal therapy in genotype 4 patients - Sanaa KAMAL (Egypt)
  • 12:00 Round table - All speakers
  • 15:00 Round table - All speakers
  • 16:00 - 16:30 Coffee break
  • 16:50 1989 -2009 : HCV twenty years after From B to non B to C : the historical evolution of hepatitises viruses - Harvey ALTER (USA)
  • 17:30 The history of the "natural history" of hepatitis C - Leonard SEEFF (USA)
  • 18:00 Awards ceremonyw
  • 20:00 Congress Dinner

Hepatitis B - Tuesday, January 20th 2009

  • 08:30 Natural history of HBV and long-term outcome under treatment - Yun-Fan LIAW (Taiwan)
  • 08:50 How to prevent, diagnose and overcome resistance under nucleos(t)ide analogs ? - Fabien ZOULIM (France)
  • 09:10 New endpoints. Back to the future with Australia Antigen ? - Maurizia BRUNETTO (Italy)
  • 09:30 Round table - All speakers
  • 10:00 - 10:30 Coffee Break
  • 10:30 Why do I treat my patients with nucleos(t)ide analogs ? - Sam LEE (Canada)
  • 10:45 Why do I treat my patients with pegylated interferon ? - George LAU (Hong Kong)
  • 11:00 Round table - All Speakers
  • 11:30 Why do I treat my patients with nucleos(t)ide analogs ? - Pietro LAMPERTICO (Italy)
  • 11:45 Why do I treat my patients with pegylated interferon ? - Robert PERRILLO (USA)
  • 12:00 Round table - All speakers
  • 14:00 EASL clinical pratice guidelines : management of chronic hepatitis B - Patrick MARCELLIN (France)
  • 14:15 Hepatitis B and pregnancy : an underestimated issue - Maureen JONAS (USA)
  • 15:15 Screening and diagnosis of hepatocellular carcinoma - Massimo COLOMBO (Italy)
  • 15:35 New drugs for hepatocellular carcinoma - Jordi BRUIX (Spain)
  • 15:55 Round table